# Coalition for Epidemic Preparedness Innovations

> Coalition for Epidemic Preparedness Innovations is a VC fund backing Biotechnology. See 41 investments, check sizes, portfolio and contact details. Updated…

- Type: VC Fund
- Location: Washington, United States
- Total investments: 41
- Last investment: Jul 2026
- Lead investor: 95%
- Last updated: Aug 2026
- Website: https://cepi.net/

Coalition for Epidemic Preparedness Innovations is a VC fund in Washington focused on Biotechnology and Health Care. The Coalition for Epidemic Preparedness Innovations (CEPI) is a non profit organisation. CEPI wants to galvanise the development of new vaccines against diseases we know could cause the next devastating epidemic.

## Contacts

5 contacts available for Coalition for Epidemic Preparedness Innovations. Shizune tracks 6 team members at Coalition for Epidemic Preparedness Innovations. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/coalition-for-epidemic-preparedness-innovations-cepi?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Grant | $3.2M–$42M |
| Post-IPO Equity | $2.5M–$145M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 25 | 61% |
| Health Care | 18 | 44% |
| Pharmaceutical | 13 | 32% |
| Medical | 10 | 24% |
| Life Science | 7 | 17% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 27 | 66% |
| Post-IPO Equity | 3 | 7% |
| Seed | 2 | 5% |
| Funding Round | 1 | 2% |
| Post-IPO Debt | 1 | 2% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 15 | 37% |
| India | 4 | 10% |
| United Kingdom | 3 | 7% |
| France | 2 | 5% |
| China | 1 | 2% |

14 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Malika Almansouri | Regulatory Affairs | 0 | https://shizune.co/investors/profile/malika-almansouri |
| Renske Hesselink | Senior Scientist CMC | 0 | https://shizune.co/investors/profile/renske-hesselink |
| Anand Ekambaram | Executive Director | 1 | https://shizune.co/investors/profile/anand-ekambaram-00a2 |
| Frederik Kristensen | Deputy CEO | 0 | https://shizune.co/investors/profile/frederik-kristensen |
| Nicholas Jackson | Head of Programs and Innovation, R&D | 0 | https://shizune.co/investors/profile/nicholas-jackson |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hilleman Laboratories | Hilleman Laboratories is a non-profit and global welfare organization proprietor of a research and vaccine organization created to fill gaps in reduced environments. By utilizing advanced biotechnology with a focus on thermo-stability, ease of administration decreased footprint and economy, the firm aims to develop an innovative vaccinationplatform and offer affordable vaccines for unusual diseases to the general public. | $8.5M | Grant | Jul 30, 2026 | https://x.com/hillemanlabs/ |
| POP Biotechnologies | POP Biotechnologies is a Buffalo, NY, life sciences company committed to improving the health of individuals with next-generation nanomedicine solutions | $9.7M | Grant | Jun 03, 2026 | http://www.popbiotech.com/ |
| Moderna | Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies insidepatient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck. | $50M | Grant | Jun 01, 2026 | http://www.modernatx.com |
| University of Oxford | Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in afederal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.The collegiate system is at the heart of the University’s success, giving students and academics the benefits of belonging both to a large, internationally renowned institution and to a small, interdisciplinary academic community. It brings together leading academics and students across subjects and year groups and from different cultures and countries, helping to foster the intense interdisciplinary approach that inspires much of the outstanding research, <a href="https://www.dissertationcorp.co.uk/">dissertation help</a> achievement of the University and makes Oxford a leader in so many fields. | $8.6M | Grant | Jun 01, 2026 | http://ox.ac.uk/ |
| International AIDS Vaccine Initiative | International AIDS Vaccine Initiative is a not-for-profit organization which ensure use of preventive HIV vaccines throughout the world. | $3.2M | Grant | Jun 01, 2026 | https://x.com/iavi |
| Alveo Technologies | Alveo Technologies is changing the world by applying cutting edge advances in sensing, microfluidics, and bioassays to create the next-generation of disease and personal care diagnostic devices.Their innovative products connect and empower consumers, healthcare professionals and treatment providers with the ability to know sooner, act faster, andmake better-informed decisions. Advanced diagnostics clear the path to more personalized medicine and better outcomes. | $200K | Grant | May 26, 2026 | http://www.alveotechnologies.com |
| Analysis Zero | Analysis Zero is in stealth mode. |  | Seed | Apr 16, 2026 |  |
| Centivax | Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services. | $26M | Grant | Feb 12, 2026 | https://www.centivax.com |
| Moderna | Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies insidepatient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck. | $54.3M | Grant | Dec 18, 2025 | http://www.modernatx.com |
| POP Biotechnologies | POP Biotechnologies is a Buffalo, NY, life sciences company committed to improving the health of individuals with next-generation nanomedicine solutions | $1.5M | Grant | Jul 24, 2025 | http://www.popbiotech.com/ |

10 of 41 investments shown.

## Co-investors
- [Bill & Melinda Gates Foundation](https://shizune.co/investors/profile/bill-melinda-gates-foundation) — VC Fund, 2 deals together
- [Horizon Europe](https://shizune.co/investors/profile/horizon-europe) — VC Fund, 2 deals together
- [Military Infectious Diseases Research Program](https://shizune.co/investors/profile/military-infectious-diseases-research-program) — VC Fund, 1 deal together
- [National Institutes of Health](https://shizune.co/investors/profile/national-institutes-of-health) — VC Fund, 1 deal together
- [United States Navy Bureau of Medicine and Surgery](https://shizune.co/investors/profile/united-states-navy-bureau-of-medicine-and-surgery) — VC Fund, 1 deal together
- [U.S. Department of Agriculture](https://shizune.co/investors/profile/u-s-department-of-agriculture) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Investinor](https://shizune.co/investors/profile/investinor) — VC Fund
- [Skyfall Ventures](https://shizune.co/investors/profile/skyfall-ventures) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Norway](https://shizune.co/investors/biotechnology-investors-norway)
- [Biotechnology VC Funds in Norway](https://shizune.co/investors/biotechnology-vc-funds-norway)
- [Biotech Investors in Norway](https://shizune.co/investors/biotech-investors-norway)
- [Biotech VC Funds in Norway](https://shizune.co/investors/biotech-vc-funds-norway)
- [Artificial intelligence VC Funds in Norway](https://shizune.co/investors/artificial-intelligence-vc-funds-norway)

## FAQ

### What does Coalition for Epidemic Preparedness Innovations invest in?

Coalition for Epidemic Preparedness Innovations invests primarily in Biotechnology, Health Care and Pharmaceutical startups, most often at Grant and Post-IPO Equity stage. Most of the 41 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Coalition for Epidemic Preparedness Innovations's check size?

Coalition for Epidemic Preparedness Innovations typically joins rounds of $3.2M–$42M at Grant and $2.5M–$145M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Coalition for Epidemic Preparedness Innovations participates in.

### How do I contact Coalition for Epidemic Preparedness Innovations?

Public channels for Coalition for Epidemic Preparedness Innovations include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Coalition for Epidemic Preparedness Innovations?

The team at Coalition for Epidemic Preparedness Innovations includes Malika Almansouri (Regulatory Affairs), Renske Hesselink (Senior Scientist CMC) and Anand Ekambaram (Executive Director), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co